Our top pick for
Beginners
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy ProShares Ultra Nasdaq Biotechnology stock
Own ProShares Ultra Nasdaq Biotechnology stock in just a few minutes.
ProShares Ultra Nasdaq Biotechnology is a n/a business based in the US. ProShares Ultra Nasdaq Biotechnology shares (BIB) are listed on the NASDAQ and all prices are listed in US Dollars.
How to buy shares in ProShares Ultra Nasdaq Biotechnology
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – BIB – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Active traders
Our top pick for
Building a portfolio
What's in this guide?
ProShares Ultra Nasdaq Biotechnology share price
Use our graph to track the performance of BIB stocks over time.ProShares Ultra Nasdaq Biotechnology shares at a glance
Information last updated 2021-03-10.
| 52-week range | $35.49 - $113.06 |
|---|---|
| 50-day moving average | $98.58 |
| 200-day moving average | $81.98 |
| Wall St. target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | N/A |
Buy ProShares Ultra Nasdaq Biotechnology shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy ProShares Ultra Nasdaq Biotechnology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
ProShares Ultra Nasdaq Biotechnology financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | 0% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | N/A |
| Market capitalisation | $0 |
TTM: trailing 12 months
ProShares Ultra Nasdaq Biotechnology share dividends
We're not expecting ProShares Ultra Nasdaq Biotechnology to pay a dividend over the next 12 months.
ProShares Ultra Nasdaq Biotechnology share price volatility
Over the last 12 months, ProShares Ultra Nasdaq Biotechnology's shares have ranged in value from as little as $35.49 up to $113.06. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ProShares Ultra Nasdaq Biotechnology's is 1.87. This would suggest that ProShares Ultra Nasdaq Biotechnology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
ProShares Ultra Nasdaq Biotechnology overview
The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified. .
Frequently asked questions
More guides on Finder
-
How to buy TC Bancshares (TCBC) stock when it goes public
Everything we know about the TC Bancshares IPO, plus information on how to buy in.
-
How to buy Soulgate (SSR) stock when it goes public
Everything we know about the Soulgate IPO, plus information on how to buy in.
-
How to buy Alzamend Neuro (ALZN) stock when it goes public
Everything we know about the Alzamend Neuro IPO, plus information on how to buy in.
-
How to buy Singular Genomics Systems (OMIC) stock when it goes public
Everything we know about the Singular Genomics Systems IPO, plus information on how to buy in.
-
How to buy Golden Sun Education Group Limited (GSUN) stock when it goes public
Everything we know about the Golden Sun Education Group Limited IPO, plus information on how to buy in.
-
How to buy Phillips Edison & Company (PECO) stock when it goes public
Everything we know about the Phillips Edison & Company IPO, plus information on how to buy in.
-
How to buy FIGS (FIGS) stock when it goes public
Everything we know about the FIGS IPO, plus information on how to buy in.
-
How to buy DLocal Limited (DLO) stock when it goes public
Everything we know about the DLocal Limited IPO, plus information on how to buy in.
-
How to buy Torchy’s Tacos (BIB.US) stock when it goes public
Everything we know about the Torchy’s Tacos IPO, plus information on how to buy in.
-
How to buy Dutch Bros Coffee (BIB.US) stock when it goes public
Everything we know about the Dutch Bros Coffee IPO, plus information on how to buy in.
Ask an Expert